{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:26:47Z","timestamp":1789982807888,"version":"4.0.1"},"reference-count":43,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T00:00:00Z","timestamp":1426464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KN1106"],"award-info":[{"award-number":["01KN1106"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Post\u2010transplant cyclophosphamide is increasingly used as graft\u2010versus\u2010host disease (Gv<jats:styled-content style=\"fixed-case\">HD<\/jats:styled-content>) prophylaxis in the setting of bone marrow transplantation. No data have been published on the use of single\u2010agent Gv<jats:styled-content style=\"fixed-case\">HD<\/jats:styled-content> prophylaxis with post\u2010transplant cyclophosphamide in the setting of peripheral blood stem cell transplantation (<jats:styled-content style=\"fixed-case\">PBSCT<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a phase <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content> trial, 11 patients with myeloma or lymphoma underwent conditioning with fludarabine and busulfan followed by T\u2010replete <jats:styled-content style=\"fixed-case\">PBSCT<\/jats:styled-content> and application of 50\u00a0mg\/kg\/d of cyclophosphamide on day+3 and +4 without other concurrent immunosuppression (IS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Median time to leukocyte, neutrophil, and platelet engraftment was 18, 21, and 18\u00a0d. The incidence of grade <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>\u2013<jats:styled-content style=\"fixed-case\">IV<\/jats:styled-content> and grade <jats:styled-content style=\"fixed-case\">III<\/jats:styled-content>\u2013<jats:styled-content style=\"fixed-case\">IV<\/jats:styled-content> Gv<jats:styled-content style=\"fixed-case\">HD<\/jats:styled-content> was 45% and 27%, with a non\u2010relapse mortality (NRM) of 36% at one and 2\u00a0yr. After median follow\u2010up of 927\u00a0d, overall and relapse\u2010free survival was 64% and 34%. Three patients did not require any further systemic IS until day+100 and thereafter. Analysis of immune reconstitution demonstrated rapid T\u2010 and <jats:styled-content style=\"fixed-case\">NK<\/jats:styled-content>\u2010cell recovery. B\u2010 and <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>3+\/<jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>161+<jats:styled-content style=\"fixed-case\">NK<\/jats:styled-content>\/T\u2010cell recovery was superior in patients not receiving additional IS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Post\u2010transplant cyclophosphamide as sole IS in <jats:styled-content style=\"fixed-case\">PBSCT<\/jats:styled-content> is feasible and allows rapid immune recovery. Increased rates of severe acute Gv<jats:styled-content style=\"fixed-case\">HD<\/jats:styled-content> explain the observed NRM and may advise a temporary combination partner such as <jats:styled-content style=\"fixed-case\">mT<\/jats:styled-content>or\u2010inhibitors in the <jats:styled-content style=\"fixed-case\">PBSCT<\/jats:styled-content> setting.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ejh.12541","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T07:12:58Z","timestamp":1424675578000},"page":"27-35","source":"Crossref","is-referenced-by-count":65,"title":["<scp>OCTET<\/scp>\u2010<scp>CY<\/scp>: a phase <scp>II<\/scp> study to investigate the efficacy of post\u2010transplant cyclophosphamide as sole graft\u2010versus\u2010host prophylaxis after allogeneic peripheral blood stem cell transplantation"],"prefix":"10.1111","volume":"96","author":[{"given":"Udo","family":"Holtick","sequence":"first","affiliation":[{"name":"Stem Cell Transplantation Program Department I of Internal Medicine Center for Integrated Oncology CIO K\u00f6lnBonn University Hospital of Cologne Cologne Germany"},{"name":"Cologne Interventional Immunology Department I of Internal Medicine University Hospital of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens\u2010Markus","family":"Chemnitz","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation Program Department I of Internal Medicine Center for Integrated Oncology CIO K\u00f6lnBonn University Hospital of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Shimabukuro\u2010Vornhagen","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation Program Department I of Internal Medicine Center for Integrated Oncology CIO K\u00f6lnBonn University Hospital of Cologne Cologne Germany"},{"name":"Cologne Interventional Immunology Department I of Internal Medicine University Hospital of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Theurich","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation Program Department I of Internal Medicine Center for Integrated Oncology CIO K\u00f6lnBonn University Hospital of Cologne Cologne Germany"},{"name":"Cologne Interventional Immunology Department I of Internal Medicine University Hospital of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geothy","family":"Chakupurakal","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation Program Department I of Internal Medicine Center for Integrated Oncology CIO K\u00f6lnBonn University Hospital of Cologne Cologne Germany"},{"name":"Cologne Interventional Immunology Department I of Internal Medicine University Hospital of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Krause","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation Program Department I of Internal Medicine Center for Integrated Oncology CIO K\u00f6lnBonn University Hospital of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Fiedler","sequence":"additional","affiliation":[{"name":"Cologne Interventional Immunology Department I of Internal Medicine University Hospital of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Luznik","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center and Department of Oncology Johns Hopkins University School of Medicine Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hellmich","sequence":"additional","affiliation":[{"name":"Institute of Medical Statistics, Informatics and Epidemiology University of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Wolf","sequence":"additional","affiliation":[{"name":"Medical Clinic III for Oncology, Haematology and Rheumatology Center for Integrated Oncology CIO K\u00f6lnBonn University Hospital Bonn Bonn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hallek","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation Program Department I of Internal Medicine Center for Integrated Oncology CIO K\u00f6lnBonn University Hospital of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"von Bergwelt\u2010Baildon","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation Program Department I of Internal Medicine Center for Integrated Oncology CIO K\u00f6lnBonn University Hospital of Cologne Cologne Germany"},{"name":"Cologne Interventional Immunology Department I of Internal Medicine University Hospital of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Scheid","sequence":"additional","affiliation":[{"name":"Stem Cell Transplantation Program Department I of Internal Medicine Center for Integrated Oncology CIO K\u00f6lnBonn University Hospital of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,16]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60237-3"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198603203141201"},{"key":"e_1_2_7_4_1","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft\u2010versus\u2010host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash RA","year":"2000","journal-title":"Blood"},{"key":"e_1_2_7_5_1","first-page":"2303","article-title":"Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft\u2010versus\u2010host disease prophylaxis after HLA\u2010identical sibling bone marrow transplantation","volume":"92","author":"Ratanatharathorn V","year":"1998","journal-title":"Blood"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704647"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3868"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.11.005"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(89)80053-1"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.1.213"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198708000-00021"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2002.v8.pm11939602"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.03.005"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.11.011"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-438408"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.3523"},{"key":"e_1_2_7_17_1","first-page":"3351","article-title":"Myeloablative Conditioning with PBSC grafts for T\u2010replete haploidentical donor hematopoietic cell transplantation using post\u2010transplant cyclophosphamide results in universal engraftment, low rates of Gvhd, NRM and excellent survival outcomes: an analysis of two consecutive phase II studies from a single center","volume":"122","author":"Solomon SR","year":"2013","journal-title":"Blood"},{"key":"e_1_2_7_18_1","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1182\/blood.V122.21.4620.4620","article-title":"Early and favourable immune reconstitution after unmanipulated haploidentical stem cell transplantation with high dose post\u2010transplant cyclophosphamide regardless intensity of conditioning regimen","volume":"122","author":"Perez\u2010Corral AM","year":"2013","journal-title":"Blood"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.02.001"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.03.003"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-009-8139-0"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.0625"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-587477"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.020"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203517"},{"key":"e_1_2_7_26_1","first-page":"CD010189","article-title":"Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults","volume":"4","author":"Holtick U","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_27_1","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1182\/blood.V120.21.4200.4200","article-title":"A matched controlled analysis of post\u2010transplant cyclophosphamide (CY) versus tacrolimus and mini\u2010dose methotrexate in matched sibling and unrelated donor transplant recipients receiving reduced\u2010intensity conditioning: post\u2010transplant CY is associated with higher rates of acute Gvhd","volume":"120","author":"Alousi AM","year":"2012","journal-title":"Blood"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.07.020"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006960"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2012.09.005"},{"key":"e_1_2_7_31_1","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1182\/blood.V122.21.4615.4615","article-title":"Tracking T cell dynamics in the first month after Haplo\u2010HSCT with post\u2010transplant cyclophosphamide reveals a predominant contribution of memory stem T cells to the early phase of immune reconstitution","volume":"122","author":"Peccatori J","year":"2013","journal-title":"Blood"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.06.019"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.12.008"},{"key":"e_1_2_7_34_1","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.V122.21.2118.2118","article-title":"Post\u2010transplant cyclophosphamide Haplo\u2010HSCT revised: peripheral blood stem cell graft and sirolimus to enhance immune reconstitution and graft versus leukemia effect in patients with active leukemia","volume":"122","author":"Greco R","year":"2013","journal-title":"Blood"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(89)90015-9"},{"key":"e_1_2_7_36_1","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka D","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.09.004"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-251595"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404775"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.01.008"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.192"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2011.00036"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04500.x"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.6832"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.12541","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.12541","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T15:38:51Z","timestamp":1695742731000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.12541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1111\/ejh.12541"],"URL":"https:\/\/doi.org\/10.1111\/ejh.12541","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,16]]}}}